Medicare Coverage Guide
Medicare GLP-1 Bridge Program 2026: Requirements, Forms and How to Get the $50 Copay
The CMS Medicare GLP-1 Bridge lets eligible Part D beneficiaries get branded Zepbound, Wegovy or Foundayo for a flat $50 per 30-day supply — with no patient enrollment, just a prior authorization your prescriber files.
- Flat $50 copay for branded, FDA-approved GLP-1s
- Wegovy®, Zepbound® KwikPen® only, or Foundayo™
- No patient enrollment — a prescriber files the prior authorization
- Three BMI tiers; some diagnoses route you to standard Part D
$50 per 30-day supply (July 2026 – Dec 2027)
Free 3-minute check · Plan verified before you pay · Found runs the route for adults 65–75
By Charly P. · Not medically reviewed · 11 min read
Updated August 2026 · Program details from CMS
- Branded FDA-approved GLP-1s
- $50 per 30-day supply
- No patient sign-up
- CMS demonstration
The Medicare GLP-1 Bridge program went live on July 1, 2026, and it is the first time Medicare has broadly paid for a GLP-1 prescribed for weight loss. Eligible Part D beneficiaries pay a flat $50 per 30-day supply for Zepbound® KwikPen®, Wegovy® or Foundayo™ — branded medications that run to hundreds of dollars a month without coverage. There is no application to fill in and no enrolment window to hit. The gate is clinical, and it is opened by a prior authorization your prescriber submits on your behalf. If you would rather have a clinical team handle the prescription and the paperwork end to end, Found runs the Bridge route for adults 65–75 and checks your plan before you pay anything.
Medicare GLP-1 Bridge Program at a Glance
| Program name | Medicare GLP-1 Bridge (CMS demonstration) |
|---|---|
| Start date | July 1, 2026 |
| End date | December 31, 2027 |
| Your cost | $50 per 30-day supply, flat |
| Covered drugs | Wegovy® (injection and tablet), Zepbound® KwikPen® only, Foundayo™ (orforglipron) |
| Who is eligible | Age 18+, enrolled in a Part D plan (PDP or MA-PD), meeting one of three BMI tiers |
| Disqualifying diagnoses | Type 2 diabetes, moderate-to-severe sleep apnea, MASH — these route to Part D |
| Enrollment | None — no patient sign-up or application form |
| Paperwork | Prescriber-submitted prior authorization to the CMS central processor |
| Decision target | Within 72 hours |
| Counts toward deductible? | No |
| Counts toward the $2,100 out-of-pocket cap? | No |
| Extra Help / LIS applies? | No |
| Estimated eligible beneficiaries | Roughly 3.8 million |
What Actually Changed on July 1, 2026
Medicare Part D has been barred by statute from covering drugs used for weight reduction since the benefit was created. That is why, before July 2026, the only route to a covered GLP-1 was a qualifying non-obesity diagnosis — Wegovy for cardiovascular risk reduction, Zepbound for obstructive sleep apnea — and why everyone else paid cash.
The Bridge does not repeal that exclusion. It sidesteps it. CMS built a nationwide demonstration that sits outside the Part D benefit entirely: your plan sponsor carries no risk, does not have to opt in, and never sees the claim. A single central processor handles prior authorization, adjudication and pharmacy payment, and manufacturers agreed to a net price of about $245 per 30-day supply. You pay $50 of that; the demonstration covers the rest. The window is 18 months.
The $50 copay window closes December 31, 2027
Start Your Free Eligibility Check →Found verifies your Part D plan and files the prior authorization before you pay anything
Medicare GLP-1 Bridge Program Requirements
Three things have to be true at once: your plan type, your age, and your clinical picture at the moment GLP-1 therapy begins. Miss any one and the prior authorization is denied.
1. Plan and age requirements
- ✓You are 18 or older.
- ✓You are actively enrolled in an eligible Part D plan — a standalone prescription drug plan (PDP) or a Medicare Advantage plan that includes drug coverage (MA-PD).
- ✓The drug is prescribed to reduce excess body weight and maintain weight reduction, alongside lifestyle modification.
- ✓You are not already receiving a GLP-1 through your Part D benefit for another indication.
2. The three BMI tiers
You need to fall into exactly one of these at therapy initiation:
| Tier | BMI | Required condition |
|---|---|---|
| Tier 1 | 35 or higher | None — BMI alone qualifies, with lifestyle modification |
| Tier 2 | 30 or higher | Heart failure, uncontrolled hypertension, or chronic kidney disease stage 3a or worse |
| Tier 3 | 27 or higher | Prediabetes, prior heart attack or stroke, or symptomatic peripheral artery disease |
3. The diagnoses that disqualify you
This is the part that surprises people, because it inverts the old rules. Under the pre-Bridge system, a sleep apnea or diabetes diagnosis was the thing that unlocked coverage. Under the Bridge, those same diagnoses push you back out.
- ✕Type 2 diabetes — covered through standard Part D instead, not the Bridge.
- ✕Moderate-to-severe obstructive sleep apnea — Zepbound is FDA-approved for this and routes through Part D.
- ✕MASH (metabolic dysfunction-associated steatohepatitis) — also routes through Part D.
The logic is that CMS built the Bridge to cover the population Part D cannot reach. If an approved non-obesity indication already gets you covered, the older route may leave you better off anyway, since Part D spending counts toward your out-of-pocket cap and Bridge spending does not. Our Medicare GLP-1 bridge program comparison walks through which route fits which diagnosis.
Takes about 3 minutes · No card required
Which Drugs the Medicare GLP-1 Bridge Covers
| Medication | Formulations covered | What it is |
|---|---|---|
| Wegovy® | All formulations — injection and oral tablet | Semaglutide, from Novo Nordisk |
| Zepbound® | KwikPen® only | Tirzepatide, from Eli Lilly — the most-prescribed obesity medication in the U.S. |
| Foundayo™ | All formulations | Orforglipron, Eli Lilly’s once-daily oral GLP-1 pill, FDA-approved April 2026 |
Zepbound: KwikPen only
Zepbound is the single covered drug with a formulation restriction, and it catches people out at the pharmacy counter. Only the multi-dose KwikPen is included. Single-dose Zepbound pens and vials are excluded, as are pen needles — budget for those separately or ask your pharmacist whether they are covered another way. If your prescription was written for a vial before July 2026, it needs rewriting for the KwikPen before a Bridge claim will process.
Injection or pill?
The Bridge is the first Medicare program where an oral GLP-1 is a real option: both Foundayo and the Wegovy tablet are covered in full. Foundayo is a small molecule rather than a peptide, so unlike the Wegovy pill it carries no food, water or timing restrictions. Trial data puts orforglipron around 11% average body-weight reduction at 72 weeks, below the 15–20% seen with the highest injectable doses — a trade of magnitude for convenience. We break the pill options down in our Foundayo pill provider guide.
Zepbound, Wegovy or Foundayo — $50/month if you qualify
Check Coverage for Your Medication →Free eligibility check · About 3 minutes · No commitment
How to Enroll in the Medicare GLP-1 Bridge Program
Search volume for “how to enroll in Medicare GLP-1 Bridge program” is high, and the answer is counter-intuitive: there is no enrollment. No application, no sign-up page, no open enrolment period, no separate premium. If you are in a Part D plan and you meet the clinical criteria, access is triggered by a prescription plus an approved prior authorization. Here is the actual sequence.
- 1.Confirm your plan type
You need active Part D drug coverage — a standalone PDP or a Medicare Advantage plan with drug coverage. Original Medicare with no drug plan does not reach the Bridge. Check your plan at Medicare.gov or call 1-800-MEDICARE.
- 2.See a prescriber and document the clinical picture
A physician, nurse practitioner or physician assistant needs your current BMI and any qualifying condition on record. This can be your regular doctor or a telehealth clinician — the prescriber does not need to be enrolled in Medicare for the Bridge.
- 3.Get the prescription written for a covered formulation
Wegovy injection or tablet, Foundayo, or the Zepbound KwikPen. A prescription for a single-dose Zepbound pen or vial will not process.
- 4.Send the prescription to a pharmacy
The pharmacy submits the claim to the Medicare GLP-1 Bridge — not to your Part D plan — and that claim triggers a prior authorization request back to your prescriber, typically within 24 to 72 hours.
- 5.Your prescriber completes the prior authorization
They fill in the CMS Bridge form and submit it to the central processor via CoverMyMeds or fax. CMS targets a decision within 72 hours. You do not submit anything.
- 6.Pay $50 and refill
Once approved, each 30-day supply costs $50. Refills do not require a new prior authorization unless you switch to a different Bridge medication.
Steps two through five are where people lose weeks — a prescriber who has never filed a Bridge request, a pharmacy that routes the claim to the Part D plan by mistake, a form returned for a missing BMI. That is precisely the friction a telehealth program removes: Found handles the prescription and the prior authorization together, which collapses steps two through five into one intake — we covered that launch in Found Health’s Medicare Part D GLP-1 announcement. Our Found Medicare GLP-1 Bridge review covers what the membership costs on top of the $50.
Prescription and prior authorization handled by one clinical team
The Medicare GLP-1 Bridge Prior Authorization Form (PDF)
Everything hinges on one document: the Medicare GLP-1 Bridge Prior Authorization Request Form. CMS publishes it as a PDF at cms.gov/files/document/glp-1-bridge.pdf, linked from the information-for-providers page.
Who submits the form
Only the prescriber. This is not a patient-fillable form, and downloading it yourself will not speed anything up — there is no beneficiary submission channel. Prescribers file it electronically through CoverMyMeds or by fax to 1-800-530-2404, addressed to the demonstration central processor rather than to your Part D plan.
What the form asks
| Length | One page of contact fields plus roughly a dozen yes/no attestation questions |
|---|---|
| Patient details | Name, Medicare number, date of birth, contact information |
| Prescriber details | Name, NPI, practice contact details, signature |
| Clinical attestations | Age 18+, BMI tier met at initiation, qualifying condition, lifestyle modification in place |
| Exclusion attestations | No type 2 diabetes, no moderate-to-severe sleep apnea, no MASH, not already on a Part D GLP-1 |
| Legal weight | Signed under penalty of perjury; CMS may verify against Medicare claims data |
| Submission | CoverMyMeds (electronic) or fax 1-800-530-2404 |
| Turnaround | CMS targets a decision within 72 hours |
| Refills | No new prior authorization needed unless switching Bridge medications |
Two practical notes. First, because the attestation is sworn, a prescriber who has not personally documented your BMI and qualifying condition will not sign it — get those into your chart before the appointment. Second, if the request is denied, the appeal goes through Medicare, not through your Part D plan, which is a different phone tree than most beneficiaries expect.
Don't want to chase your doctor for the form?
Get Your Prior Authorization Filed for You →Found's clinicians write the prescription and file the Bridge prior authorization as one process
Medicare GLP-1 Coverage 2026: What the $50 Copay Does Not Do
The headline number is genuinely good. The fine print costs real money, and it is the least-reported part of Medicare GLP-1 coverage in 2026.
- ✕The $50 does not count toward your Part D deductible.
- ✕It does not count toward the $2,100 annual out-of-pocket cap for 2026 — so twelve months of Bridge fills leave your catastrophic-coverage math exactly where it started.
- ✕Extra Help and other low-income subsidies do not apply to it. A beneficiary paying $0 for other drugs still pays the full $50 here.
- ✕It cannot be spread across the year through the Medicare Prescription Payment Plan.
- ✕Coverage ends December 31, 2027, and the replacement is unsettled.
On the last point: the Bridge was meant as a stopgap ahead of the BALANCE Model, but CMS has indefinitely delayed BALANCE’s Medicare Part D component after too few plan sponsors opted in. In practice, plan for an 18-month window and treat anything after it as unknown — KFF’s analysis tracks where that stands. Set against what the same branded drugs cost without coverage, $600 a year for twelve Bridge fills is still the cheapest branded GLP-1 access available to anyone in the United States. You can sanity-check your own numbers with our insurance cost calculator.
Bridge vs Cash-Pay: Which Route Is Actually Cheaper for You
| Route | Typical monthly cost | Best for |
|---|---|---|
| Medicare GLP-1 Bridge | $50 per 30-day supply | Part D members who clear a BMI tier and have none of the excluded diagnoses |
| Bridge via a telehealth program | $50 copay plus membership from about $49/mo | Anyone who wants the prescription and prior authorization handled for them |
| Standard Part D coverage | Plan copay, counts toward your out-of-pocket cap | Beneficiaries with type 2 diabetes, sleep apnea or MASH |
| Cash-pay compounded GLP-1 | Under $100/mo | Anyone outside the criteria, or without Part D coverage at all |
| Cash-pay branded GLP-1 | Varies by pharmacy and manufacturer program | People who want branded medication with no eligibility gate |
If you fail the criteria, do not treat that as the end of it. The cash-pay market has no eligibility gate at all, and the compounded tier now starts under $100 a month — see our ranking of the best weight loss treatments for 2026 for what that field looks like.
Find out in 3 minutes whether the $50 route is open to you
Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
The Bottom Line
Our Editorial Take
The Medicare GLP-1 Bridge is the best branded GLP-1 pricing available to anyone in the country right now, and the requirements are narrower than the headlines suggest: a BMI tier you have to hit exactly, a plan type you have to hold, and three common diagnoses that push you out rather than in. There is no enrollment to complete — the entire process turns on a prior authorization form only your prescriber can file, and the 72-hour clock does not start until a pharmacy submits a claim.
If you are on Part D and think you clear a tier, the fastest path is a clinician who files Bridge requests routinely rather than one filing their first. And if you do not qualify, the cash-pay market starts under $100 a month with no paperwork at all.
Branded Zepbound/Wegovy/Foundayo at a $50/mo copay
Check Your $50 Medicare GLP-1 Eligibility Now →Free · 3 minutes · Plan verified before you pay anything
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.